The Eighth Asia Dengue Summit emphasized the importance of regional solidarity, science-based strategies, and shared responsibility in combating dengue fever. The summit, held in Manila over three days, underscored the urgent need to address a disease that continues to impact millions of people and strain public health systems in Asia.

Organized by the Asia Dengue Voice and Action (ADVA), the summit focused on more than just medical advancements. It also highlighted the necessity of rebuilding public trust in vaccines, strengthening surveillance systems, and increasing community engagement to prevent the spread of the disease.

The Philippines, known for being the epicenter of large-scale dengue immunization trials, has faced skepticism from the public due to past vaccine controversies. However, recent studies show a resurgence in vaccine confidence, with the Philippines leading a 2023 survey on trust in dengue vaccines, according to Professor Lulu Bravo, an ADVA advisor.

Bravo emphasized that transparency, scientific communication, and community involvement are crucial in maintaining trust in the next generation of dengue vaccines.

Professor Tikki Pangestu, an international advisor for ADVA, highlighted the safety and effectiveness of the new vaccine compared to its predecessor. Pangestu stated that the second-generation vaccine has positive safety data spanning over four years and does not require pre-testing, making it more widely accessible.

Dr. Maria Rosario Capeding, chair of the summit's organizing committee, shared a success story from San Pablo City, where early dengue vaccine trials were conducted. Despite previous vaccine program controversies, the community continued to participate in research, even volunteering for the country's first Covid-19 vaccine trials, showcasing the level of trust built with the people.

The summit addressed gaps in the Philippines' public health infrastructure, particularly in disease surveillance. Speakers criticized the lack of timely and transparent data reporting, noting the absence of recent dengue data from the Philippines on the World Health Organization's global dashboard, unlike neighboring countries like Vietnam and Malaysia.

Panelists at the summit urged the media to play an active role in disseminating accurate information and combating misinformation, which has hindered vaccine uptake in the past. Pangestu stressed the importance of effective communication, especially when children are involved, to build trust and confidence in vaccines.

ADVA leaders emphasized that achieving zero dengue deaths by 2030 is feasible but requires continuous collaboration among governments, healthcare providers, private partners, and the public. Professor Datuk Zulkifli Ismail, ADVA chairman, highlighted the need for collective action, stating that with improved tools, data, and understanding, it is crucial to act now to prevent future outbreaks.